SYNTHESIS OF N-[4-({4-[(5-METHYL-1, 3, 4-THIADIAZOL-2-YL)SULFAMOYL] PHENYL}SULFAMOYL)PHENYL]AMINE: AN IMPURITY IN THE ANTIBACTERIAL DRUG SULFAMETHIZOLE
Abstract
The process for the preparation of antibacterial compound 4-amino-N-(5-methyl-1, 3, 4-thiadiazol-2-yl)benzenesulfonamide (Sulfamethizole) 4 involves the reaction of 2-amino-5-methyl-1, 3, 4-thiadiazole 1 with 4-acetamidobenzenesulfonyl chloride 2 followed by alkaline hydrolysis of the intermediate N-{4-[(5-methyl-1, 3, 4-thiadiazol-2-yl)sulfamoyl]phenyl}acetamide 3. The HPLC analysis of sulfamethizole showed the formation of an impurity which was isolated and identified as N-[4-({4-[(5-methyl-1, 3, 4-thiadiazol-2-yl) sulfamoyl] phenyl} sulfamoyl) phenyl] amine 6. This impurity is the result of the reaction of unreacted sulfonyl chloride 2 with sulfamethizole to form N-[4-({4-[(5-methyl-1, 3, 4-thiadiazol-2-yl)sulfamoyl]phenyl}sulfamoyl)phenyl]acetamide 5 followed by alkaline hydrolysis of the acetamido group. The structure was further confirmed by independent synthesis.
Keywords:
Sulfamethizole, antibacterial, 4-sulfanilinomyl sulfamethizole, HPLC analysisDOI
https://doi.org/10.25004/IJPSDR.2012.040209References
2. Seelemann M. Bacteriostatic effect of newer sulfonamides on streptococcus of different serological groupings. Deut. Tierarztl. Wochenschr. 1942; 50: 221-226.
3. Rune Frisk A. Quantitative chemotherapeutic utilization of 13 N-heterocyclic derivatives of sulfanilamide in-vitro. Acta Med. Scand. 1942; 110: 337-358.
4. Tappi G, Migliardi C. Several heterocyclic derivatives of sulfanilamide. Arch. Sci. biol. 1941; 27: 170-175.
5. Rune Frisk A. Sulfanilamides Chemotherapeutic evaluation of N1-Substituted sulfanilamides. Acta Med. Scand. 1943; 142: 1-199.
6. Guha PC, Dasgupta DB. Sulfanilamide derivatives possessing heterocyclic rings. Sulfanilamidothiadiazoles. Current Sci. 1943; 12: 220.
7. Guha PC, Dasgupta DB. Sulfanilamides I. N1- Thiadiazolyl sulfanilamides. J. Indian Chem. Soc. 1945; 22: 79-81.
8. Tappi G, Migliardi C. Several sulfanilamide derivatives. Arch. Sci. Biol. 1942; 28: 472.
9. Hartmann M, Cueni F, Druey J, Meyenburg HV. Sulfonamides. US 1942; 2, 386, 852.
10. Peddie BA, Little PJ. Sulphamethizole in urinary tract infections. J. Antimicrob. Chemother. 1979; 5(2): 195-200.
11. Tappi G. Heterocyclic derivatives of sulfanilamide. Recl. Trav. Chim. 1943; 62: 207-209.
12. Roblin Jr RO, Winnek PS. Substituted aryl sulfamidothiadiazoles. US 1944; 2, 358, 31.
13. Kinberg T, Aktiebolaget H. p-Substituted phenyl sulfonamido-1, 3, 4-thiadiazole compounds. GB 1944; 564, 92.
14. Soc. Pour L’ind. Chim. a Bale. Sulfonamide derivatives. CH 1944; 230, 859.
15. Mayer R, Viaud P, Appell F. p-Aminophenylsulfonamidothiadiazoles. Fr. 1941; 866, 175.
16. Hans W, Hildbert W. Synthesis of aminothiadiazoles and the corresponding sulfonamide derivatives. Arch. Pharma. 1951; 284: 53-62.
17. Masaki O, Mifune A, Higashijima T, Nagato S. 1, 3, 4-Thiadiazolederivatives. Several reactions of aminothiadiazoles. J. Pharma. Soc. Japan 1951; 71: 481-484.
18. Ishikawa M, Kikkawa I. Sulfathiadiazole derivatives. Ann. Rept. Shionogi Res. Lab. 1954; 4: 36-38.
Published
Abstract Display: 524 
PDF Downloads: 607 How to Cite
Issue
Section
Copyright (c) 2012 G B Talagadadeevi, B R Vancha, S Anusuri, M. Rao. Jampani
This work is licensed under a Creative Commons Attribution 4.0 International License.
